Orthofix Medical Inc. (OFIX) recently announced the receipt of FDA 510(k) clearance to market its Rodeo Telescopic Nail. The nail implant is likely to stabilize the patient’s limb while also elongating (or telescoping) to accommodate the natural growth of pediatric patients. Price Performance In the past six months, OFIX’s shares have gained 41.2% compared with the industry’s rise of 23.9%. The S&P 500 increased 16.2% in the same time frame. Image Source: Zacks Investment Research More on the News The Rodeo ...